Showing 2,861 - 2,880 results of 18,171 for search 'significantly ((((linear decrease) OR (((we decrease) OR (a decrease))))) OR (teer decrease))', query time: 0.68s Refine Results
  1. 2861
  2. 2862
  3. 2863
  4. 2864
  5. 2865
  6. 2866
  7. 2867
  8. 2868
  9. 2869
  10. 2870
  11. 2871
  12. 2872
  13. 2873
  14. 2874
  15. 2875

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  16. 2876

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  17. 2877

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  18. 2878

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  19. 2879

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  20. 2880

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”